How a new drug interacts with common medications
Treatments studied
This study tests how a new drug called MDR-001 works when taken with two common medications (rifampin and itraconazole). Researchers want to understand if these drugs affect each other in healthy volunteers, which helps ensure the new drug is safe before testing it in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult aged 18–55 years old
- You weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female, with a normal body mass index
- You have not smoked more than 5 cigarettes per day in the last 3 months
- You agree not to get pregnant and use non-hormonal birth control for 6 months after the study ends
- You have no history of significant health problems, including headaches, drug allergies, or stomach ulcers
- You can follow a standard diet and attend all study visits without missing doses or tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body processes and tolerates a new experimental drug (MDR-001) in people with mild to moderate liver disease. The research helps doctors understand if the drug is safe and how it works when liver function is reduced.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
This study tests how a new drug (HDM1002) interacts with two other common medicines—rifampin and itraconazole—in healthy volunteers. The results will help doctors understand how to safely use the drug with other medications.
This study tests how a new experimental drug (BGB-58067) moves through your body and how two common medications affect that process. Researchers need healthy volunteers to understand if these drug interactions are safe.
This early-stage study tests how a common antifungal medication (itraconazole) changes how your body processes a new experimental drug called HS-10506. Researchers enroll healthy volunteers to understand safe dosing before testing in patients with real medical conditions.
This study tests how a new TB drug (Sudapyridine) interacts with two common medicines: itraconazole (an antifungal) and rifampin (a TB treatment). It also looks at how food affects the drug. The study is for healthy Chinese adults to find the safest dosing.
Hear when a new Healthy Volunteers (HV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.